Detalhe da pesquisa
1.
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer.
EMBO Rep
; 24(8): e55884, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37366231
2.
Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation.
Mol Cancer
; 23(1): 78, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643157
3.
Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment.
Semin Cell Dev Biol
; 85: 153-163, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29155219
4.
Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients.
Cytokine
; 141: 155471, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33607398
5.
YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.
Am J Respir Crit Care Med
; 200(7): 888-899, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31166114
6.
Innate immune mediators in cancer: between defense and resistance.
Immunol Rev
; 274(1): 290-306, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27782320
7.
Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.
Am J Respir Crit Care Med
; 197(9): 1164-1176, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29327939
8.
Complement inhibition in cancer therapy.
Semin Immunol
; 25(1): 54-64, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23706991
9.
New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations.
Int J Cancer
; 135(11): 2516-27, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24473991
10.
Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression.
J Immunol
; 189(9): 4674-83, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23028051
11.
Fasting and fasting-mimicking conditions in the cancer immunotherapy era.
J Physiol Biochem
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587595
12.
Interaction with FcγRIIB is critical for the agonistic activity of anti-CD40 monoclonal antibody.
J Immunol
; 187(4): 1754-63, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21742972
13.
A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer.
Front Immunol
; 14: 1272570, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37841258
14.
The complement system as a regulator of tumor-promoting activities mediated by myeloid-derived suppressor cells.
Cancer Lett
; 549: 215900, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087681
15.
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination.
Front Immunol
; 13: 991311, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36300124
16.
Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma.
Dis Model Mech
; 15(1)2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34870316
17.
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer.
Cancer Discov
; 12(5): 1356-1377, 2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35191482
18.
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis.
Cancer Lett
; 529: 70-84, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34971753
19.
The Complement System in Ovarian Cancer: An Underexplored Old Path.
Cancers (Basel)
; 13(15)2021 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34359708
20.
Molecular biomarkers in early stage lung cancer.
Transl Lung Cancer Res
; 10(2): 1165-1185, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33718054